ADAR1 Capital Management, LLC

ADAR1 Capital Management, LLC reported 266 holdings worth US$2.19B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

ADAR1 Capital Management, LLC reported 266 holdings worth US$2.19B as of Sep 30, 2026. Largest: Abivax SA, State Street SPDR S&P 500 ETF and Protagonist Therapeutics, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
266
Value as reported
US$2.19B

The filing in full

CompanySharesValue as reported% of portfolio
Abivax SA2.05MUS$203M9.3%
State Street SPDR S&P 500 ETF178KUS$135M6.2%
Protagonist Therapeutics, Inc.951KUS$134M6.1%
Roivant Sciences Ltd.3.08MUS$113M5.1%
Immunovant, Inc.2.12MUS$71.5M3.3%
Denali Therapeutics Inc.2.07MUS$42.8M2.0%
Alpha Architect 1-3 Month Box ETF337KUS$39.9M1.8%
Septerna, Inc.974KUS$38.1M1.7%
Agios Pharmaceuticals, Inc.1.14MUS$37.9M1.7%
Aura Biosciences, Inc.5.39MUS$33.8M1.5%
Viking Therapeutics, Inc.1.03MUS$33.7M1.5%
Cytokinetics, Incorporated461KUS$30.4M1.4%
Insmed Incorporated230KUS$26.2M1.2%
Freenome, Inc.1.65MUS$25.9M1.2%
Celldex Therapeutics, Inc.799KUS$25.9M1.2%
Anteris Technologies Global Corp.3.24MUS$25.2M1.1%
BridgeBio Pharma, Inc.379KUS$25M1.1%
Praxis Precision Medicines, Inc.84,751US$24.7M1.1%
Fulcrum Therapeutics, Inc.6.65MUS$24.6M1.1%
Vir Biotechnology, Inc.2.16MUS$24.1M1.1%
DBV Technologies SA2.01MUS$23.6M1.1%
Enanta Pharmaceuticals, Inc.1.73MUS$22.8M1.0%
Editas Medicine, Inc.8.89MUS$22.8M1.0%
Spyre Therapeutics, Inc.238KUS$21.2M0.96%
Enliven Therapeutics, Inc.443KUS$20.3M0.92%
Nurix Therapeutics, Inc.813KUS$19.3M0.88%
Sanofi SA465KUS$19.2M0.87%
Revolution Medicines, Inc.87,509US$18M0.82%
Sarepta Therapeutics, Inc.952KUS$17.3M0.79%
Maze Therapeutics, Inc.637KUS$17.3M0.79%
Adlai Nortye Group Ltd.997KUS$16M0.73%
Rallybio Corporation926KUS$15.9M0.73%
Nektar Therapeutics258KUS$15.6M0.71%
Taysha Gene Therapies, Inc.3.06MUS$14.9M0.68%
Monopar Therapeutics Inc.179KUS$14.3M0.65%
Janux Therapeutics, Inc.824KUS$14.2M0.65%
Rhythm Pharmaceuticals, Inc.139KUS$13.2M0.60%
Cogent Biosciences, Inc.392KUS$12.6M0.57%
Regeneron Pharmaceuticals, Inc.16,446US$12.5M0.57%
State Street SPDR Bloomberg 1-3 Month T-Bill ETF136KUS$12.4M0.57%
Tenax Therapeutics, Inc.6.52MUS$12.3M0.56%
Monte Rosa Therapeutics, Inc.1.01MUS$12M0.55%
AbCellera Biologics Inc.822KUS$12M0.55%
Establishment Labs Holdings Inc.186KUS$11.9M0.54%
Vogenx Inc522KUS$11.9M0.54%
Inhibikase Therapeutics, Inc.5.71MUS$11.7M0.53%
Ovid Therapeutics Inc.4.56MUS$11.4M0.52%
Avalyn Pharma Inc.398KUS$11.3M0.52%
Amylyx Pharmaceuticals, Inc.367KUS$10.7M0.49%
Helix Acquisition Corp. III1MUS$10.5M0.48%
Beam Therapeutics Inc.421KUS$10.3M0.47%
Vor Biopharma Inc.531KUS$10.1M0.46%
Edgewise Therapeutics, Inc.243KUS$9.87M0.45%
Kazia Therapeutics Ltd968KUS$9.29M0.42%
Climb Bio, Inc.793KUS$9.09M0.41%
Replimune Group, Inc.656KUS$8.68M0.40%
Opus Genetics, Inc.1.78MUS$8.63M0.39%
Summit Therapeutics Inc.497KUS$8.4M0.38%
Vaxcyte, Inc.146KUS$8.31M0.38%
Research Alliance Corporation III767KUS$8.31M0.38%
Amanat Acquisition Corp750KUS$7.99M0.36%
Inventiva SA2.07MUS$7.62M0.35%
JATT II Acquisition Corp683KUS$7.6M0.35%
Ionis Pharmaceuticals, Inc.170KUS$7.57M0.35%
Rainier Acquisition Corporation743KUS$7.55M0.34%
C4 Therapeutics, Inc.2.23MUS$7.44M0.34%
MapLight Therapeutics, Inc.725KUS$7.39M0.34%
Savara, Inc.1.41MUS$7.28M0.33%
Perspective Therapeutics, Inc.2.62MUS$7.2M0.33%
Silence Therapeutics PLC630KUS$6.88M0.31%
Biohaven Ltd.502KUS$6.7M0.31%
Destiny Tech100 Inc210KUS$6.49M0.30%
TCGX Acquisition Corp.500KUS$6.26M0.29%
Research Alliance Corporation IV525KUS$6.22M0.28%
OnKure Therapeutics, Inc.2.24MUS$6.1M0.28%
CytomX Therapeutics, Inc.2.2MUS$6M0.27%
Pliant Therapeutics, Inc.5.51MUS$5.95M0.27%
Mineralys Therapeutics, Inc.227KUS$5.71M0.26%
Oaktree Acquisition Corp. III Life Sciences516KUS$5.62M0.26%
Equillium, Inc.3.45MUS$5.6M0.26%
Biogen Inc.24,400US$5.51M0.25%
Krystal Biotech, Inc.16,420US$5.46M0.25%
Korro Bio, Inc.540KUS$5.35M0.24%
Lexeo Therapeutics, Inc.1.58MUS$5.33M0.24%
Contineum Therapeutics, Inc.385KUS$5.17M0.24%
Ardelyx, Inc.1.49MUS$5.1M0.23%
Whitehawk Therapeutics, Inc.1.34MUS$5.04M0.23%
BHAV Acquisition Corp495KUS$5.02M0.23%
JATT III Acquisition Corp454KUS$5M0.23%
Capricor Therapeutics, Inc.527KUS$4.99M0.23%
Prime Medicine, Inc.1.6MUS$4.88M0.22%
Inspire Medical Systems, Inc.70,029US$4.86M0.22%
Tarsus Pharmaceuticals, Inc.62,500US$4.77M0.22%
MacroGenics, Inc.1.23MUS$4.77M0.22%
Boundless Bio, Inc.1.89MUS$4.75M0.22%
Acumen Pharmaceuticals, Inc.2.11MUS$4.69M0.21%
Danaher Corporation21,132US$4.68M0.21%
Alector, Inc.2.51MUS$4.65M0.21%
Pfizer, Inc.162KUS$4.63M0.21%
Arrowhead Pharmaceuticals, Inc.69,200US$4.53M0.21%

Every holding of ADAR1 Capital Management, LLC

Source

Download original · View original at SEC

Related